These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 14699433

  • 1. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M.
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [Abstract] [Full Text] [Related]

  • 2. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    Avale ME, Nemirovsky SI, Raisman-Vozari R, Rubinstein M.
    J Neurosci Res; 2004 Oct 15; 78(2):289-96. PubMed ID: 15378510
    [Abstract] [Full Text] [Related]

  • 3. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K, Davids E, Tarazi FI, Baldessarini RJ.
    Psychopharmacology (Berl); 2002 Apr 15; 161(1):100-6. PubMed ID: 11967637
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate.
    Keck TM, Suchland KL, Jimenez CC, Grandy DK.
    Pharmacol Biochem Behav; 2013 Feb 15; 103(4):831-41. PubMed ID: 23262298
    [Abstract] [Full Text] [Related]

  • 5. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q, Lu G, Antonio GE, Mak YT, Rudd JA, Fan M, Yew DT.
    Neurochem Int; 2007 May 15; 50(6):848-57. PubMed ID: 17395336
    [Abstract] [Full Text] [Related]

  • 6. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.
    Neuroscience; 2010 Jun 02; 167(4):1183-91. PubMed ID: 20211696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB.
    J Clin Child Psychol; 2001 Mar 02; 30(1):98-109. PubMed ID: 11294083
    [Abstract] [Full Text] [Related]

  • 9. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L.
    Biol Psychiatry; 2005 Feb 01; 57(3):229-38. PubMed ID: 15691523
    [Abstract] [Full Text] [Related]

  • 10. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K, Togashi H, Yoshioka M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb 01; 23(1):47-55. PubMed ID: 12690641
    [Abstract] [Full Text] [Related]

  • 11. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.
    Neurosci Lett; 2011 Oct 17; 504(1):35-9. PubMed ID: 21907264
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D4 receptor-deficient mice, congenic on the C57BL/6J background, are hypersensitive to amphetamine.
    Kruzich PJ, Suchland KL, Grandy DK.
    Synapse; 2004 Aug 17; 53(2):131-9. PubMed ID: 15170825
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.
    LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL.
    Mol Psychiatry; 1996 May 17; 1(2):121-4. PubMed ID: 9118321
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D4 receptor gene and attention deficit hyperactivity disorder.
    Frank Y, Pergolizzi RG, Perilla MJ.
    Pediatr Neurol; 2004 Nov 17; 31(5):345-8. PubMed ID: 15519116
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF.
    J Clin Psychiatry; 2006 Nov 17; 67 Suppl 8():7-12. PubMed ID: 16961424
    [Abstract] [Full Text] [Related]

  • 17. The dopamine D4 receptor and the hyperactivity phenotype: a developmental-epidemiological study.
    Mill JS, Caspi A, McClay J, Sugden K, Purcell S, Asherson P, Craig I, McGuffin P, Braithwaite A, Poulton R, Moffitt TE.
    Mol Psychiatry; 2002 Nov 17; 7(4):383-91. PubMed ID: 11986982
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S, Muñetón-Gómez VC, de Ceballos ML, Bernson M, Moratalla R.
    Eur J Neurosci; 2008 Feb 17; 27(3):580-92. PubMed ID: 18279311
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D4 receptor stimulation in GABAergic projections of the globus pallidus to the reticular thalamic nucleus and the substantia nigra reticulata of the rat decreases locomotor activity.
    Erlij D, Acosta-García J, Rojas-Márquez M, González-Hernández B, Escartín-Perez E, Aceves J, Florán B.
    Neuropharmacology; 2012 Feb 17; 62(2):1111-8. PubMed ID: 22108379
    [Abstract] [Full Text] [Related]

  • 20. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN, Kourrich S, Rezazadeh SM, Stewart J, Arvanitogiannis A.
    Behav Brain Res; 2006 Feb 28; 167(2):379-82. PubMed ID: 16246436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.